CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,137,000 | -13.9% | 25,000 | 0.0% | 0.03% | +7.7% |
| Q1 2018 | $1,320,000 | -22.4% | 25,000 | 0.0% | 0.03% | -16.1% |
| Q4 2017 | $1,700,000 | -31.2% | 25,000 | -16.7% | 0.03% | -35.4% |
| Q3 2017 | $2,472,000 | +164.1% | 30,000 | +200.0% | 0.05% | +65.5% |
| Q2 2017 | $936,000 | -63.3% | 10,000 | -75.0% | 0.03% | -58.0% |
| Q1 2017 | $2,547,000 | -25.6% | 40,000 | -57.9% | 0.07% | -41.5% |
| Q3 2016 | $3,425,000 | – | 95,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |